Frontier Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$351K Buy
2,138
+111
+5% +$17K 0.02% 193
2020
Q1
$281K Buy
2,027
+400
+25% +$55K 0.02% 197
2019
Q4
$214K Sell
1,627
-422
-21% -$48.9K 0.01% 300
2019
Q3
$229K Buy
2,049
+127
+7% +$14.1K 0.01% 256
2019
Q2
$213K Buy
+1,922
New +$226K 0.01% 240
2014
Q4
Sell
-5,181
Closed -$336K 179
2014
Q3
$336K Buy
5,181
+72
+1% +$4.56K 0.05% 129
2014
Q2
$318K Sell
5,109
-62,948
-92% -$3.76M 0.05% 125
2014
Q1
$4.01M Buy
68,057
+6,950
+11% +$388K 0.71% 40
2013
Q4
$3.12M Sell
61,107
-1,566
-2% -$78.4K 0.58% 40
2013
Q3
$3.15M Buy
62,673
+15,655
+33% +$820K 0.58% 37
2013
Q2
$2.29M Buy
+47,018
New +$2.56M 0.46% 42

Other funds holding LLY

Frontier Investment Management's LLY Position: Q2 2020 in Review

Frontier Investment Management increased its Eli Lilly (LLY) stake by 5.5% in Q2 2020, buying an estimated $17K and bringing the position to 2,138 shares worth $351K. The position accounts for 0.02% of the portfolio, ranked #193.

Frontier Investment Management first reported a position in LLY in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.01M in Q1 2014. 1,764 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

  • Frontier Investment Management held 2,138 shares of Eli Lilly worth $351K as of Q2 2020.
  • Frontier Investment Management bought 111 Eli Lilly shares in Q2 2020, an estimated $17K.
  • Eli Lilly made up 0.02% of Frontier Investment Management's portfolio in Q2 2020, its #193 holding.
  • Frontier Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 11 quarters since.
  • Frontier Investment Management's Eli Lilly position peaked at $4.01M in Q1 2014.
  • 1,764 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.